U.S. Physical Therapy (USPH) Stock Price, News & Analysis

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" USPH shares.
View USPH analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued 12-month price objectives for U.S. Physical Therapy's stock. Their USPH share price targets range from $117.00 to $138.00. On average, they anticipate the company's stock price to reach $125.67 in the next twelve months. This suggests a possible upside of 20.9% from the stock's current price.
View analysts price targets for USPH or view top-rated stocks among Wall Street analysts.

U.S. Physical Therapy's stock was trading at $93.14 at the beginning of 2024. Since then, USPH stock has increased by 11.6% and is now trading at $103.93.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024.
View our USPH earnings forecast.

U.S. Physical Therapy, Inc. (NYSE:USPH) issued its earnings results on Tuesday, May, 7th. The company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.58 by $0.07. The company earned $155.70 million during the quarter, compared to the consensus estimate of $153.30 million. U.S. Physical Therapy had a net margin of 4.67% and a trailing twelve-month return on equity of 8.52%. The firm's quarterly revenue was up 4.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.59 EPS.

U.S. Physical Therapy announced a quarterly dividend on Tuesday, February 27th. Stockholders of record on Tuesday, March 12th will be given a dividend of $0.44 per share on Friday, April 5th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.69%. The ex-dividend date is Monday, March 11th. This is a boost from the stock's previous quarterly dividend of $0.43.
Read our dividend analysis for USPH.

U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.76 per share and currently has a dividend yield of 1.67%. The company has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 130.37%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, USPH will have a dividend payout ratio of 57.52% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for USPH.

ETFs with the largest weight of U.S. Physical Therapy (NYSE:USPH) stock in their portfolio include Small Cap US Equity Select ETF (RNSC), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Pacer US Small Cap Cash Cows Growth Leaders ETF (CAFG), Texas Capital Texas Equity Index ETF (TXS) and AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF (SMIG).iShares U.S. Healthcare Providers ETF (IHF).

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

U.S. Physical Therapy's stock is owned by many different institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (2.50%), Principal Financial Group Inc. (0.54%), Sei Investments Co. (0.53%), Norden Group LLC (0.42%), Russell Investments Group Ltd. (0.32%) and Bridge City Capital LLC (0.25%). Insiders that own company stock include Anne Motsenbocker, Carey P Hendrickson, Christopher J Reading, Clayton Trier, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Mark J Brookner and Richard Binstein.
View institutional ownership trends.

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.